Multiple Oral Dose Safety, Tolerability And Pharmacokinetic Study Of PF-04287881 In Healthy Adult Subjects

NCT01026545 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Tract Infections

Interventions

DRUG: PF-04287881
DRUG: Placebo
DRUG: PF-04287881
DRUG: Placebo
DRUG: PF-04287881
DRUG: Placebo
DRUG: PF-04287881
DRUG: Placebo
DRUG: PF-04287881
DRUG: Placebo
DRUG: PF-04287881
DRUG: Placebo

Sponsor

Pfizer